{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:34:32Z","timestamp":1792611272357,"version":"4.5.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec><jats:title>Objectives:<\/jats:title><jats:p>With recent approval of standalone HPV testing and increasing uptake of HPV vaccination, some have postulated that we are moving toward a \u201cpost-Pap\u201d era of cervical cancer prevention. However, the total number cases that have been prevented by Pap smear screening as well as its impact on racial disparities are unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We estimated national cervical cancer incidence from 1976 to 2009 using the Surveillance, Epidemiology, and End Result database. Screening data were obtained from the literature and National Cancer Institute Progress Reports. We examined early, late, and race-specific trends in cancer incidence, and calculated the estimated number of cancers prevented over the past 3 decades.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>From 1976 to 2009, there was a significant decrease in the incidence of early-stage cervical cancer, from 9.8 to 4.9 cases per 100,000 women (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Late-stage disease incidence also decreased, from 5.3 to 3.7 cases per 100,000 women (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). The incidence among black women decreased from 26.9 to 9.7 cases per 100,000 women (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), a greater decline compared with that of white women and women of other races. After adjusting for \u201cprescreening era\u201d rates of cervical cancer, we estimate that Pap smears were associated with a reduction of between 105,000 and 492,000 cases of cervical cancer over the past 3 decades in the United States.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>A large number of early-stage and late-stage cervical cancers were prevented and racial disparity in cancer rates were reduced during an era of widespread Pap smear screening.<\/jats:p><\/jats:sec>","DOI":"10.1097\/coc.0000000000000264","type":"journal-article","created":{"date-parts":[[2016,1,24]],"date-time":"2016-01-24T11:29:33Z","timestamp":1453634973000},"page":"289-294","source":"Crossref","is-referenced-by-count":102,"title":["Impact of Widespread Cervical Cancer Screening"],"prefix":"10.1097","volume":"41","author":[{"given":"Daniel X.","family":"Yang","sequence":"first","affiliation":[{"name":"Yale University School of Medicine"},{"name":"Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela R.","family":"Soulos","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine"},{"name":"Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigette","family":"Davis","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine"},{"name":"Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary P.","family":"Gross","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine"},{"name":"Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center"},{"name":"Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Yu","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine"},{"name":"Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center"},{"name":"Therapeutic Radiology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(79)90172-7","article-title":"Does screening by \u201cPap\u201d smears help prevent cervical cancer? A case-control study","volume":"2","author":"Clarke","year":"1979","journal-title":"Lancet"},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.currproblcancer.2007.01.001","article-title":"Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States","volume":"31","author":"Akers","year":"2007","journal-title":"Curr Probl Cancer"},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2105\/AJPH.85.6.791","article-title":"The screening histories of women with invasive cervical cancer, Connecticut","volume":"85","author":"Janerich","year":"1995","journal-title":"Am J Public Health"},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1158\/1055-9965.EPI-11-1158","article-title":"Prevention of invasive cervical cancer in the United States: past, present, and future","volume":"21","author":"Pierce Campbell","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10552-007-9056-y","article-title":"Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003","volume":"18","author":"McDougall","year":"2007","journal-title":"Cancer Causes Control"},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/cncr.20467","article-title":"Persistent area socioeconomic disparities in US incidence of cervical cancer, mortality, stage, and survival, 1975-2000","volume":"101","author":"Singh","year":"2004","journal-title":"Cancer"},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ygyno.2012.08.021","article-title":"Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009","volume":"127","author":"Simard","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ygyno.2012.05.035","article-title":"Changing demographics of cervical cancer in the United States (1973-2008)","volume":"126","author":"Ward","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R13-20230928","first-page":"620","article-title":"Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014\u2014United States","volume":"63","author":"Stokley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJMct0806938","article-title":"HPV vaccination for the prevention of cervical intraepithelial neoplasia","volume":"361","author":"Kahn","year":"2009","journal-title":"N Engl J Med"},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1016\/j.vaccine.2013.04.051","article-title":"Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States","volume":"31","author":"Chesson","year":"2013","journal-title":"Vaccine"},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0025-7125(05)70169-3","article-title":"Principles of screening","volume":"83","author":"Nielsen","year":"1999","journal-title":"Med Clin North Am"},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-8258(75)90001-3","article-title":"Control of cancer of the uterine cervix by cytologic screening","volume":"3","author":"Dickinson","year":"1975","journal-title":"Gynecol Oncol"},{"key":"R20-20230928","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2307\/4592543","article-title":"Survey of beliefs about cancer detection and taking Papanicolaou tests","volume":"80","author":"Kegeles","year":"1965","journal-title":"Public Health Rep"},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.currproblcancer.2012.03.007","article-title":"Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance","volume":"36","author":"Park","year":"2012","journal-title":"Curr Probl Cancer"},{"key":"R26-20230928","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"key":"R27-20230928","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/cncr.28794","article-title":"Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009","volume":"120","author":"Yang","year":"2014","journal-title":"Cancer"},{"key":"R28-20230928","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/gyno.1999.5524","article-title":"Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening","volume":"75","author":"Plaxe","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R29-20230928","first-page":"1015","article-title":"Morbidity from cervical cancer: effects of cervical cytology and socioeconomic status","volume":"35","author":"Lundin","year":"1965","journal-title":"J Natl Cancer Inst"},{"key":"R30-20230928","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO;2-B","article-title":"The role of cervical cytology in the declining morbidity and mortality of cervical cancer","volume":"34","author":"Cramer","year":"1974","journal-title":"Cancer"},{"key":"R31-20230928","first-page":"701","article-title":"Cancer incidence and mortality trends among whites in the United States, 1947-84","volume":"79","author":"Devesa","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"R32-20230928","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0962280206070621","article-title":"Efficient interval estimation for age-adjusted cancer rates","volume":"15","author":"Tiwari","year":"2006","journal-title":"Stat Methods Med"},{"key":"R33-20230928","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cncr.25065","article-title":"Cervical cancer prevention: new tools and old barriers","volume":"116","author":"Scarinci","year":"2010","journal-title":"Cancer"},{"key":"R34-20230928","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R35-20230928","first-page":"23","article-title":"Sexual and reproductive risk factors for invasive squamous cell cervical cancer","volume":"79","author":"Brinton","year":"1987","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 1","key":"R36-20230928","first-page":"S1","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier","year":"2006","journal-title":"Vaccine"},{"issue":"5A","key":"R37-20230928","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"key":"R38-20230928","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","article-title":"Incidence of cervical squamous intraepithelial lesions in HIV-infected women","volume":"283","author":"Ellerbrock","year":"2000","journal-title":"JAMA"},{"key":"R39-20230928","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.1989.03420110069026","article-title":"Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer","volume":"261","author":"Slattery","year":"1989","journal-title":"JAMA"},{"issue":"suppl 3","key":"R41-20230928","first-page":"S3\/171","article-title":"Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination","volume":"24","author":"Franco","year":"2006","journal-title":"Vaccine"},{"key":"R42-20230928","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(13)62028-0","article-title":"Embracing a new era in cervical cancer screening","volume":"383","author":"Isidean","year":"2014","journal-title":"Lancet"},{"key":"R43-20230928","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.vaccine.2010.10.051","article-title":"Worsening disparities in HPV vaccine utilization among 19-26 year old women","volume":"29","author":"Dempsey","year":"2011","journal-title":"Vaccine"},{"key":"R44-20230928","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2105\/AJPH.81.5.646","article-title":"Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type","volume":"81","author":"Mandelblatt","year":"1991","journal-title":"Am J Public Health"},{"key":"R45-20230928","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archfami.9.5.439","article-title":"Clinical and demographic predictors of late-stage cervical cancer","volume":"9","author":"Ferrante","year":"2000","journal-title":"Arch Fam Med"},{"key":"R46-20230928","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/00005650-199712000-00006","article-title":"Time trends in late-stage diagnosis of cervical cancer. Differences by race\/ethnicity and income","volume":"35","author":"Mitchell","year":"1997","journal-title":"Med Care"},{"key":"R47-20230928","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jamainternmed.2014.4021","article-title":"Human Papillomavirus testing for primary cervical cancer screening: is it time to abandon Papanicolaou testing?","volume":"174","author":"Feldman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R48-20230928","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinternmed.2010.134","article-title":"Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs. Papanicolaou testing alone: what screening intervals are physicians recommending?","volume":"170","author":"Saraiya","year":"2010","journal-title":"Arch Intern Med"},{"key":"R49-20230928","doi-asserted-by":"crossref","first-page":"46.e41","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"Wright","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R50-20230928","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R51-20230928","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/cncr.29445","article-title":"Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007","volume":"121","author":"Weinmann","year":"2015","journal-title":"Cancer"},{"key":"R52-20230928","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1055-9965.EPI-13-0973","article-title":"A population-based evaluation of cervical screening in the United States: 2008-2011","volume":"23","author":"Cuzick","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R53-20230928","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ygyno.2015.01.538","article-title":"Transitioning to a new era in cervical cancer screening","volume":"136","author":"Schiffman","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R54-20230928","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.canep.2015.05.002","article-title":"Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008-2013","volume":"39","author":"Sauer","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"R55-20230928","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.2012.100","article-title":"The harms of screening: new attention to an old concern","volume":"307","author":"Woolf","year":"2012","journal-title":"JAMA"},{"key":"R56-20230928","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.2013.108415","article-title":"Overdiagnosis and overtreatment in cancer: An opportunity for improvementemerging overdiagnosis and overtreatmentviewpoint","volume":"310","author":"Esserman","year":"2013","journal-title":"JAMA"},{"key":"R57-20230928","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jamainternmed.2014.3901","article-title":"Cancer screening in older persons: a new age of wonder","volume":"174","author":"Gross","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R58-20230928","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2105\/AJPH.2008.133702","article-title":"Black-White differences in hysterectomy prevalence: the CARDIA study","volume":"99","author":"Bower","year":"2009","journal-title":"Am J Public Health"},{"key":"R59-20230928","doi-asserted-by":"crossref","first-page":"34.e31","DOI":"10.1016\/j.ajog.2007.05.039","article-title":"Inpatient hysterectomy surveillance in the United States, 2000-2004","volume":"198","author":"Whiteman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R60-20230928","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"R61-20230928","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.pu.16.050195.000425","article-title":"Ecologic studies in epidemiology: concepts, principles, and methods","volume":"16","author":"Morgenstern","year":"1995","journal-title":"Annu Rev Public Health"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000421-201803000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T06:40:27Z","timestamp":1748760027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201803000-00015"}},"subtitle":["Number of Cancers Prevented and Changes in Race-specific Incidence"],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000264","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}